A genomic virulence reference map of Enterococcus faecalis reveals an important contribution of phage03-like elements in nosocomial genetic lineages to pathogenicity in a Caenorhabditis elegans infection model

Infection and Immunity
Sabina Leanti La RosaDag A Brede

Abstract

In the present study, the commensal and pathogenic host-microbe interaction of Enterococcus faecalis was explored using a Caenorhabditis elegans model system. The virulence of 28 E. faecalis isolates representing 24 multilocus sequence types (MLSTs), including human commensal and clinical isolates as well as isolates from animals and of insect origin, was investigated using C. elegans strain glp-4 (bn2ts); sek-1 (km4). This revealed that 6 E. faecalis isolates behaved in a commensal manner with no nematocidal effect, while the remaining strains showed a time to 50% lethality ranging from 47 to 120 h. Principal component analysis showed that the difference in nematocidal activity explained 94% of the variance in the data. Assessment of known virulence traits revealed that gelatinase and cytolysin production accounted for 40.8% and 36.5% of the observed pathogenicity, respectively. However, coproduction of gelatinase and cytolysin did not increase virulence additively, accounting for 50.6% of the pathogenicity and therefore indicating a significant (26.7%) saturation effect. We employed a comparative genomic analysis approach using the 28 isolates comprising a collection of 82,356 annotated coding sequences (CDS) to identify 2,32...Continue Reading

References

Dec 1, 1978·Journal of Clinical Pathology·C J Noble
Jul 1, 1990·Statistics in Medicine·Y Hochberg, Y Benjamini
Dec 5, 1974·Journal of Molecular Biology·R H WaterstonS Brenner
May 1, 1974·Genetics·S Brenner
Oct 1, 1994·Clinical Microbiology Reviews·B D JettM S Gilmore
Jul 1, 1995·The Journal of Hospital Infection·A M KearnsN F Lightfoot
Nov 27, 1996·Molecular & General Genetics : MGG·K LeenhoutsJ Kok
Jun 11, 1998·Emerging Infectious Diseases·M M HuyckeM S Gilmore
May 2, 2000·Applied and Environmental Microbiology·A SghirJ Dore
Sep 1, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M J RichardsR P Gaynes
Sep 6, 2001·Proceedings of the National Academy of Sciences of the United States of America·D A GarsinF M Ausubel
Feb 22, 2003·Infection and Immunity·Claudia Gentry-WeeksDale Baker
Jan 22, 2004·Bioinformatics·Emmanuel ParadisKorbinian Strimmer
Mar 23, 2004·Nucleic Acids Research·Robert C Edgar
Mar 2, 2005·Trends in Microbiology·Costi D SifriFrederick M Ausubel
Jun 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·Terence I MoyFrederick M Ausubel
Dec 14, 2006·Molecular Microbiology·Phillip S CoburnNathan Shankar
Feb 20, 2007·Infection and Immunity·Arash MaadaniDanielle A Garsin
Jul 6, 2007·PloS One·Shonna M McBrideMichael S Gilmore
May 27, 2008·Journal of Bacteriology·Biju JosephWerner Goebel
Apr 28, 2009·BMC Genomics·Margrete SolheimIngolf F Nes
Oct 27, 2009·The International Journal of Artificial Organs·Roberta CretiCarla Renata Arciola
Dec 8, 2009·Journal of Bacteriology·Alain BizziniAxel Hartke
Dec 17, 2009·Journal of Bacteriology·Azra YasminMalcolm J Horsburgh
Jun 24, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·I G SavaJ Huebner
Nov 26, 2010·Applied and Environmental Microbiology·Jessica R Galloway-PeñaBarbara E Murray

❮ Previous
Next ❯

Citations

Jun 16, 2016·Frontiers in Microbiology·Ana M Guzman PrietoRob J L Willems
Jan 20, 2017·Virulence·H M Sharon GohKimberly A Kline
May 4, 2017·International Journal of Molecular Sciences·Liaqat AliDaojin Yu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.